Example: stock market
Gemcitabine 200mg and 1 mg Powder for Solution for ...
MHRA PAR; GEMCITABINE 200 MG AND 1 G POWDER FOR SOLUTION FOR INFUSION, PL 20176/0048-9 6 The manufacturing process is referenced to a drug master file (DMF).
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
DCPAR for Ampicillin-Salbactam 1 g--0 5 and 2 g-1 g ...
www.mhra.gov.ukPAR Ampicillin/Sulbactam 1 g/0.5 g and 2 g/1 g powder for Solution for Injection or Infusion UK/H/4322/001-2/DC 1 Public Assessment Report Decentralised Procedure
GLYCOPYRRONIUM BROMIDE 0.2MG/ML …
www.mhra.gov.ukUKPAR Glycopyrronium Bromide 0.2 mg/ml Solution for Injection PL 00156/0115 1 GLYCOPYRRONIUM BROMIDE 0.2MG/ML SOLUTION FOR INJECTION (PL 00156/0115)
The Human Medicines Regulations 2012 – …
www.mhra.gov.ukThe Human Medicines Regulations 2012 – description of each Part This document provides a brief overview of each Part of the Human Medicines Regulations 2012 …
FULTIUM -D 800 IU CAPSULES - GOV.UK
www.mhra.gov.ukVitamin D deficiency, with levels of 25(OH)D below 25nmol/L (10ng/ml), could result in the disease rickets (or osteomalacia). The disease resulting as a deficiency is considered to be due to malabsorption
Meloxicam - GOV.UK
www.mhra.gov.ukPL 31388/0003-4 UKPAR Alpex Pharma (UK) Ltd, Meloxicam 7.5mg and 15mg Orodispersible Tablets 3 Scientific Discussion INTRODUCTION Based on the review of the data on quality, safety and efficacy, the UK granted
PL 00010/0643 - GOV.UK
www.mhra.gov.ukUKPAR Canesten HC Cream PL 00010/0643 6 All excipients comply with their respective European Pharmacopoeia monographs, except triceteareth-4-
Public Assessment Report UKPAR Canesten Combi …
www.mhra.gov.ukThis is a summary of the Public Assessment Report (PAR) for Canesten Combi Pessary & External Cream 500mg / 2% w/w pessary & cream (PL 00010/0653).
Public Assessment Report Mutual Recognition …
www.mhra.gov.ukPAR Sayana 104mg/0.65ml Suspension for Injection UK/H/0960/001/MR 1 Public Assessment Report Mutual Recognition Procedure SAYANA 104MG/0.65ML SUSPENSION FOR INJECTION
Cefixime 400 mg Film-coated Tablets, PL 22805 …
www.mhra.gov.ukMHRA PAR; CEFIXIME 400 MG FILM-COATED TABLETS, PL 22805/0032-3 2 Lay summary The Medicines and Healthcare products Regulatory Agency …
Public Assessment Report Decentralised Procedure …
www.mhra.gov.ukPublic Assessment Report Decentralised Procedure LIOTHYRONINE SODIUM 20 MICROGRAM TABLETS (liothyronine sodium) Procedure No: UK/H/6516/001/DC
Related documents
2. QUALITATIVE AND QUANTITATIVE COMPOSITION 2.1 Film ...
www.medsafe.govt.nz2.3 Solution for infusion Ciproxin 2 mg/mL: 1 glass bottle of 100 mL infusion solution contains 254.4 mg ciprofloxacin lactate, corresp. to
PRODUCT INFORMATION RINGER’S SOLUTION FOR …
www.baxterhealthcare.com.auPI Ringer’s Solution IV infusion – 26 Mar 2015 (RSI 20120719) Page 3 of 8 amounts are lost in the sweat, skin, hair, and nails. Calcium crosses the placenta and is
NORADRENALINE NOREPINEPHRINE 1 MG ML Concentrate …
www.mhra.gov.ukMHRA PAR; NORADRENALINE (NOREPINEPHRINE) 1 MG / ML CONCENTRATE FOR SOLUTION FOR INFUSION, PL 31980/0001 2 Lay summary The Medicines and Healthcare products Regulatory Agency (MHRA) granted
OSMITROL INTRAVENOUS INFUSION (MANNITOL …
www.baxterhealthcare.com.auOsmitrol Intravenous Infusion (Mannitol) Product Information Page 1 of 12 OSMITROL INTRAVENOUS INFUSION (MANNITOL INTRAVENOUS INFUSION, BP) Name of the Medicine
TOTAL PARENTERAL NUTRITION SOLUTIONS
www.kingguide.comTOTAL PARENTERAL NUTRITION SOLUTIONS ... d= ...
CIPFLOX 1. Product Name 2. Qualitative and Quantitative ...
www.medsafe.govt.nzPage 1of 22 NEW ZEALAND DATA SHEET CIPFLOX 1. Product Name CIPFLOX,100 mg, 250 mg, 500 mg, 750 mg and 2 mg/mL, film-coated tablets and solution for
FDA APPROVED: 1-18-08 Or, initial dose of 8 mg/kg over 90 ...
www.accessdata.fda.govU.S. BL 103792/5175 Amendment: Trastuzumab ⎯Genentech, Inc.